Given that methylation within SORL1, ABCA7, and other loci has been associated with AD risk [233, 234], the results suggest that epigenetic modifications (and genetic variation that affects such modifications) should be explored further for their contribution to EOAD risk. Here, ABCA7 is linked to Alzheimer disease.